Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12168487 | 0.99 | TSHR (0.51) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL12168484 | 0.97 | TSHR (0.49) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL7879723 | 0.92 | TSHR (0.51) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL26703785 | 0.90 | TSHR (0.54) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL10100422 | 0.86 | TSHR (0.49) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL21385223 | 0.86 | TSHR (0.51) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL384901 | 0.84 | TSHR (0.42) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL14445494 | 0.82 | NPC1 (0.42) | TSHRHPGDALDH1A1CYP3A4THRB | |
| SCHEMBL4644870 | 0.82 | ATM (0.39) | TSHRHPGDPRKCAATMHCAR2 | |
| SCHEMBL13882270 | 0.81 | ALDH1A1 (0.42) | TSHRALDH1A1PRKCAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040723-A | Curable composition, cured film, organic EL element, and method for producing same | JSR株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-118146493-A | Curable composition, cured film, organic EL element, method for producing the same, and compound | JSR株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-115232511-B | Sealing agent for organic EL display element | 积水化学工业株式会社 | 2023-11-24 | — | — | CN | disclosed |
| US-20230350294-A1 | Negative Photosensitive Resin Composition, Patterning Process, Interlayer Insulating Film, Surface Protection Film, And Electronic Component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| CN-115232511-A | Sealing agent for organic EL display element | 积水化学工业株式会社 | 2022-10-25 | — | — | CN | disclosed |
| CN-110583098-B | Sealing agent for organic EL display element | 积水化学工业株式会社 | 2022-07-26 | — | — | CN | disclosed |
| CN-110583098-A | Sealing agent for organic EL display element | 积水化学工业株式会社 | 2019-12-17 | — | — | CN | disclosed |
| US-8993790-B2 | Oxetane-ring-containing (meth)acrylic acid ester compound | DAICEL CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8993790-B2 | Oxetane-ring-containing (meth)acrylic acid ester compound | DAICEL CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8993790-B2 | Oxetane-ring-containing (meth)acrylic acid ester compound | DAICEL CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20130035465-A1 | RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | DAICEL CORPORATION (JP) | 2013-02-07 | — | — | US | disclosed |
| US-20130035465-A1 | RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | DAICEL CORPORATION (JP) | 2013-02-07 | — | — | US | disclosed |
| US-20120309930-A1 | CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF | DAICEL CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120309930-A1 | CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF | DAICEL CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120309930-A1 | CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF | DAICEL CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| EP-2502922-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2012-09-26 | — | — | EP | disclosed |
| EP-2502922-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2012-09-26 | — | — | EP | disclosed |
| US-20120232295-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | DAICEL CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120232295-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | DAICEL CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120232295-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | DAICEL CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035465-A1 | RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | PTGER1, RAD51, REV1 | TSHR 3867/4885HPGD 241/4885ALDH1A1 240/4885 |
| US-20120232295-A1 | OXETANE-RING-CONTAINING (METH)ACRYLIC ACID ESTER COMPOUND | OXGR1, OXER1, ASS1 | TSHR 2458/4885HPGD 341/4885ALDH1A1 46/4885 |
| US-20120309930-A1 | CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF | ARG1, ARGLU1, RAD51 | TSHR 3119/4885HPGD 685/4885ALDH1A1 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.